Immune-Related Adverse Events and Nivolumab Efficacy in NSCLC

This medical record review evaluates the relation of immune-related adverse events to nivolumab efficacy in non–small-cell lung cancer.

from Cancer via ola Kala on Inoreader http://ift.tt/2xqlPAB
via IFTTT